LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+5.43%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.57B
AUM Growth
+$1.57B
(-2.7%)
Cap. Flow
-$30.3M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
432
New
226
Increased
52
Reduced
94
Closed
41
Top Buys
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$22.4M |
| 2 |
CRISPR Therapeutics
CRSP
|
$13.5M |
| 3 |
Virtus Investment Partners
VRTS
|
$11.9M |
| 4 |
Amazon
AMZN
|
$11.8M |
| 5 |
Medifast
MED
|
$11.5M |
Top Sells
| 1 |
Merck
MRK
|
$27.7M |
| 2 |
Voya Financial
VOYA
|
$24.9M |
| 3 |
Equity Lifestyle Properties
ELS
|
$23.4M |
| 4 |
BioNTech
BNTX
|
$16.1M |
| 5 |
iShares MSCI India ETF
INDA
|
$15.5M |
Sector Composition
| 1 | Healthcare | 52.77% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Financials | 13.41% |
| 4 | Technology | 7.21% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Amgen
AMGN
$154B
| $1.24M | 0.08% |
+5,519
| New | +$1.24M |
|
127
Chevron
CVX
$324B
| $1.23M | 0.08% |
10,461
-6,273
| -37% | -$736K |
|
128
NextEra Energy, Inc.
NEE
$149B
| $1.21M | 0.08% |
12,974
-12,097
| -48% | -$1.13M |
|
129
Oracle
ORCL
$629B
| $1.2M | 0.08% |
13,744
-1,358
| -9% | -$118K |
|
130
Sherwin-Williams
SHW
$89.9B
| $1.15M | 0.07% |
+3,259
| New | +$1.15M |
|
131
Target
TGT
$41.8B
| $1.12M | 0.07% |
+4,856
| New | +$1.12M |
|
132
Broadcom
AVGO
$1.4T
| $1.1M | 0.07% |
+1,648
| New | +$1.1M |
|
133
Mondelez International
MDLZ
$79.3B
| $1.1M | 0.07% |
16,543
-2,401
| -13% | -$159K |
|
134
Edwards Lifesciences
EW
$48B
| $1.09M | 0.07% |
8,413
-7,109
| -46% | -$921K |
|
135
Medtronic
MDT
$120B
| $1.08M | 0.07% |
10,447
-5,738
| -35% | -$594K |
|
136
Eversource Energy
ES
$23.5B
| $1.07M | 0.07% |
11,737
-249
| -2% | -$22.7K |
|
137
Walmart
WMT
$779B
| $1.06M | 0.07% |
+7,321
| New | +$1.06M |
|
138
Malibu Boats
MBUU
$620M
| $1.06M | 0.07% |
15,400
| – | – |
|
139
CVS Health
CVS
$93.6B
| $1.03M | 0.07% |
9,994
-312
| -3% | -$32.2K |
|
140
Snowflake
SNOW
$77.7B
| $1.02M | 0.07% |
+3,024
| New | +$1.02M |
|
141
Kinder Morgan
KMI
$59.2B
| $1.01M | 0.06% |
63,694
-22,457
| -26% | -$356K |
|
142
Gilead Sciences
GILD
$140B
| $1.01M | 0.06% |
13,883
-679
| -5% | -$49.3K |
|
143
Idexx Laboratories
IDXX
$51.2B
| $1M | 0.06% |
+1,519
| New | +$1M |
|
144
Interpublic Group of Companies
IPG
$9.64B
| $982K | 0.06% |
26,215
-16,160
| -38% | -$605K |
|
|
NBIS
145
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $972K | 0.06% |
16,060
-168,700
| -91% | -$10.2M |
|
146
Moody's
MCO
$89.3B
| $947K | 0.06% |
+2,424
| New | +$947K |
|
147
Hershey
HSY
$37.6B
| $941K | 0.06% |
+4,863
| New | +$941K |
|
148
Booking.com
BKNG
$178B
| $938K | 0.06% |
+391
| New | +$938K |
|
149
Morgan Stanley
MS
$236B
| $936K | 0.06% |
9,535
-1,547
| -14% | -$152K |
|
150
Danaher
DHR
$145B
| $923K | 0.06% |
+2,804
| New | +$923K |
|